Loading organizations...
Key people at m1720.
M1720 operates as a venture capital firm, concentrating its investments in Seed and Series A stage US technology companies. The firm’s strategy targets prominent societal and economic themes, including labor shortages, energy security, inflation immunization, and the evolving needs of the millennial demographic. M1720 aims to identify and nurture innovative businesses addressing these critical areas, providing capital to fuel their early growth and development within the tech sector.
The firm was founded in 2023 by Chi Tsang, an experienced professional with over two decades of global technology and finance expertise. Tsang's background encompasses significant contributions in buy-side research and portfolio management, providing a foundational insight into identifying promising early-stage ventures. This deep understanding of both technology and financial markets underpins M1720's investment thesis, guiding its approach to new opportunities.
M1720 seeks to partner with technology companies that are building solutions aligned with its thematic focus, ultimately serving broader market needs. The firm’s long-term vision is centered on "seeding abundance" by backing entrepreneurial teams capable of developing transformative technologies. This forward-looking approach positions M1720 to support the next generation of innovators shaping the future across critical economic and social landscapes.
Key people at m1720.
m1720 is a venture capital firm focused on early-stage investments, particularly in technology startups. Its mission centers on supporting founders who are building transformative companies that address real-world problems with innovative solutions. The firm’s investment philosophy emphasizes backing visionary entrepreneurs with scalable business models, often in sectors such as artificial intelligence, SaaS, and digital platforms. m1720 plays a significant role in the startup ecosystem by providing not only capital but also strategic guidance and operational support, helping portfolio companies accelerate growth and navigate market challenges[8][10].
Founded by a team including Ashley Pradhan and Cierra Valor, who serve as CEO and COO of INBOLDPRINT respectively, alongside other founders like Don Mathis (CEO of SkyfireAI) and Fahad Aziz (CEO of PuppyDog), m1720 emerged from a shared vision to empower innovative startups. The founders bring diverse backgrounds in technology and entrepreneurship, which shaped the firm’s focus on early-stage tech ventures. The firm has evolved to emphasize a founder-first approach, leveraging its partners’ operational experience to provide hands-on support beyond funding[8].
m1720 is positioned at the intersection of several key trends, including the rise of AI-driven solutions and the increasing demand for SaaS platforms that streamline business operations. The timing is favorable as digital transformation accelerates across industries, creating fertile ground for startups to disrupt traditional markets. By focusing on early-stage companies, m1720 helps shape the innovation pipeline, influencing the broader ecosystem through its portfolio’s technological advancements and market impact[8][10].
Looking ahead, m1720 is likely to deepen its focus on sectors like AI and enterprise software, capitalizing on emerging technologies and market shifts. The firm’s influence is expected to grow as it continues to back visionary founders and scale innovative startups that redefine their industries. Trends such as automation, data-driven decision-making, and remote work solutions will shape m1720’s investment strategy, positioning it as a key player in nurturing the next generation of tech leaders[8][10]. This forward momentum ties back to m1720’s core mission of empowering founders to build impactful, scalable companies.
m1720 has 4 tracked investments across 4 companies. The latest tracked deal is $100K Seed in Clearly in April 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2024 | Clearly | $100K Seed | — | Openspace Ventures |
| Apr 1, 2024 | In Bold Print | $100K Pre-seed | — | — |
| Jul 1, 2022 | Octopus | $5.0M Seed | — | Openspace Ventures |
| Sep 1, 2021 | Neuroglee Therapeutics | $10.0M Series A | Openspace Ventures, EDBI | Kuldeep Rajput, Mark Wendou NIU, Raman Singh, Wendou LIU, Eisai |